Skip to Main Content

Paper Details

Homozygous KSR1 deletion attenuates morbidity but does not prevent tumor development in a mouse model of RAS-driven pancreatic cancer.
PLoS One
3
2018
KSR, KSR1, Ksr1, Ksr1+/+, Ksr1-/-, MAP kinase, RAF, RAS, RAS-driven pancreatic cancer, RNA, cancer, mice, mouse, mouse embryonic fibroblasts, oncogenic RAS, pERK, pancreatic cancer, pancreatic intraepithelial neoplastic (PanIN) lesions, tumor, tumors

Datasets

Release 1.2